Status:
UNKNOWN
Caffeine and the Autonomic Nervous System
Lead Sponsor:
LMU Klinikum
Conditions:
Autonomic Nervous System Imbalance
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Caffeine consumption has been linked to dysfunction of the autonomic nervous system. In this study the investigators analyze the effects of caffeine containing drinks (including energy drinks and coff...
Eligibility Criteria
Inclusion
- healthy individuals
- \> 18 years
Exclusion
- known cardiovascular disease
- other diseases which may influence the autonomic nervous system
- medication which may influence the autonomic nervous system
- prior caffeine consumption (\<24 hours)
Key Trial Info
Start Date :
April 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2021
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04886869
Start Date
April 1 2021
End Date
June 30 2021
Last Update
May 14 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Munich (LMU Klinikum)
Munich, Germany